PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection

PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection. Pharmacoecon. Outcomes News 495, 8 (2006). https://doi.org/10.2165/00151234-200604950-00021

Download citation

Published: 02 February 2013
Issue Date: January 2006
DOI: https://doi.org/10.2165/00151234-200604950-00021

Keywords

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection

Access this article

Rights and permissions

About this article

Cite this article

Share this article

Keywords

Search

Navigation